-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Kinnate Biopharma Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2021 to 2023.
- Kinnate Biopharma Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2023 was $2.24M, a 99.9% increase year-over-year.
- Kinnate Biopharma Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2023 was $8.53M, a 279% increase year-over-year.
- Kinnate Biopharma Inc. annual Nonoperating Income (Expense) for 2023 was $8.53M, a 279% increase from 2022.
- Kinnate Biopharma Inc. annual Nonoperating Income (Expense) for 2022 was $2.25M, a 547% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)